论文部分内容阅读
随着市场经济的不断发展和深入,制药企业面临的市场挑战越加激烈,与此同时,企业的财务管理和会计核算工作也面临、新观念、新思路的挑战,企业需要不断的发展和壮大,就必需要有一定的经营业绩和经营手段,但是,市场的激烈竞争,会给制药企业的财务管理带来一定的风险,所以,制药企业的发展和财务管理,都与企业的稳定运作有必然的联系。本文将主要对新形势下制药企业的财务管理风险进行分析和探讨,并对其所存在的问题提出建议和对策。
With the constant development of the market economy and the deepening of the market, pharmaceutical companies are facing more and more intense market challenges. At the same time, the financial management and accounting of the enterprises also face the challenge of new ideas and new ideas. Enterprises need to continuously develop and grow , It is necessary to have a certain degree of business performance and management tools. However, fierce competition in the market will bring certain risks to the financial management of pharmaceutical enterprises. Therefore, the development and financial management of pharmaceutical enterprises are linked to the stable operation of enterprises. Necessary contact. This article will mainly analyze and discuss the financial management risks of the pharmaceutical enterprises in the new situation and put forward suggestions and solutions to the existing problems.